Just a correction. J591 isn't yet commercialised, still has to do P3.
15 years is a long time, but when you're looking to make the best theranostic, they had to go back to the bench. They spent time making their copper version of a PSMA agent and found out it had the same results as pluvicto. This is where the time went(and creating an IP for their SAR tech). Luckily for most retail punters, they only IPOed when they were convinced and confident of what they had. And it also showed real conviction in Alan and the team that the people who coughed up money pre IPO continued to do so again and again before the float.
CU6 Price at posting:
$3.78 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)